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CapsaicinPolyamines (putrescine, spermidine and spermine) are important endogenous regulators of ion channels, such as
vanilloid (TRPV1), glutamatergic (NMDA or AMPA/kainate) and acid-sensitive (ASIC) receptors. In the present
study, we have investigated the possible nociceptive effect induced by polyamines and themechanisms involved
in this nociception in vivo. The subcutaneous (s.c.) injection of capsaicin (as positive control), spermine,
spermidine or putrescine producednociceptionwith ED50of 0.16 (0.07–0.39)nmol/paw, 0.4 (0.2–0.7)μmol/paw,
0.3 (0.1–0.9)μmol/paw and 3.2 (0.9–11.5)μmol/paw, respectively. The antagonists of NMDA (MK801,
1 nmol/paw), AMPA/kainate (DNQX, 1 nmol/paw) or ASIC receptors (amiloride, 100 nmol/paw) failed to reduce
the spermine-trigged nociception. However, the TRPV1 antagonists capsazepine or SB366791 (1 nmol/paw)
reduced spermine-induced nociception, with inhibition of 81±10 and 68±9%, respectively. The previous
desensitization with resiniferatoxin (RTX) largely reduced the spermine-induced nociception and TRPV1
expression in the sciatic nerve, with reductions of 82±9% and 67±11%, respectively. Furthermore, the
combination of spermine (100 nmol/paw) and RTX (0.005 fmol/paw), in doses which alone were not capable of
inducing nociception, produced nociceptive behaviors. Moreover, different concentrations of spermine (3–
300 μM) enhanced the speciﬁc binding of [3H]-RTX to TRPV1 receptor. Altogether, polyamines produce
spontaneous nociceptive effect through the stimulation of TRPV1, but not of ionotropic glutamate or ASIC
receptors.Universidade Federal de Santa
32208053; fax: +55 55 3220
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Polyamines putrescine (1,4-butane diamine), spermidine (N-(3-
aminopropyl)-1,4-butane diamine) and spermine (N,N0-bis(3-
aminopropyl)-1,4-butane diamine) are aliphatic amines initially
formed by decarboxylation of ornithine, a reaction catalyzed by the
enzyme ornithine decarboxylase (Seiler et al., 1996). Known functions
of polyamines include interactionswith several biomolecules, especially
ion channels (Childs et al., 2003; Rea et al., 2004; Wallace et al., 2003;
Williams, 1997).
In fact, various functions of the central nervous system (CNS) are
related with polyamine actions on ion channels (Scott et al., 1993).
Several in vitro and in vivo evidences have demonstrated that
polyamines can modulate N-methyl-D-aspartate (NMDA), α-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) or kainite re-
ceptors in CNS (Scott et al., 1993; Williams, 1997). It is also already
known that polyvalent cations, such as spermine, are modulators of
ASIC receptor activity (Babini et al., 2002). Interestingly, an in vitro
study has demonstrated that intracellular and extracellular poly-
amines can modulate the vanilloid receptor TRPV1 activity, a member
of the transient receptor potential (TRP) channel family (Ahern et al.,
2006). These ﬁndings suggest that polyamine could also regulate the
function of ion channels in other tissues.
TRPV1, ASIC and glutamatergic NMDA or kainate receptors are
expressed by a subset of peripheral pain-sensing neurons (Calixto et
al., 2005; Carlton, 2001; Olson et al., 1998). When such receptors are
exposed to tissue damaging stimuli, these channels become perme-
able to Na+ and Ca2+ ions, causing, in turn, neuronal depolarization
and recognition as pain stimulus. Sensory neuron ﬁring transmits
these pain signals towards the central nervous system, evoking at the
same time a variety of local tissue responses (Caterina and Julius,
2001). The peripheral administration of vanilloid, ASIC or glutamate
receptor agonists results in nociceptive behavior in mice and rats
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et al., 1992; Zhou et al., 1996). On the other hand, peripheral
administration of TRPV1, ASIC or NMDA antagonists can attenuate
nociception in models of inﬂammatory pain (Davidson et al., 1997;
Meotti et al., 2010; Santos and Calixto, 1997). Of note, the levels of
polyamines are increased in tissue and synovial ﬂuid of patients with
arthritis (Yukioka et al., 1992), suggesting polyamines could mediate
inﬂammatory pain.
Therefore, the present study aimed to assess the role of peripheral
polyamines in nociception in vivo and investigate the role of
glutamatergic NMDA and AMPA/kainite as well as ASIC and TRPV1
receptors in this action.
2. Methods
2.1. Animals
Male Swiss mice (30–35 g) maintained at 22±2 °C with free
access to water and food, under a 12:12 h light:dark cycle, were used.
Animals were acclimatized in the laboratory for at least 2 h before
testing and were used once throughout the experiments. All
experiments were conducted in accordance to the ethical guidelines
of the International Association for the Study of Pain (Zimmermann,
1983) and “International Guiding Principles for Biomedical Research
Involving Animals” (Council of International Organization of Medical
Sciences, Geneva, 1985). The number of animals and the nociceptive
stimulus were the minimum necessary to demonstrate the consistent
effects of drug treatments. This study was approved by the Committee
on the Use and Care of Laboratory Animals of our university (no.
23081.012331/2009-81).
2.2. Algogen-induced nociceptive responses
The procedure used was similar to that previously described by
Ferreira et al. (2004) and Oliveira et al. (2009). A volume of 20 μl of
capsaicin (0.01–3 nmol/paw), glutamate (10,000 nmol/paw), putres-
cine (1000–10,000 nmol/paw), spermidine (100–2000 nmol/paw) or
spermine (100–2000 nmol/paw) was injected subcutaneously (s.c.)
under the surface of the right hind paw. Separate groups of animals
received s.c. injection of the appropriated vehicle phosphate-buffered
saline (PBS) (137 mMNaCl, 27 mM KCl and 10 mM phosphate buffer)
or PBS plus ethanol 0.25% for capsaicin. Animals were placed
individually in chambers (transparent glass cylinders of 20 cm in
diameter) and were adapted for 20 min before treatment. After
challenge, mice were observed individually for 5 min and the amount
of time spent licking the injected paw was timed with a chronometer
and was considered as indicative of nociception. The dose and the
time of administration of drugs were based on pilot studies.
2.3. Involvement of NMDA, AMPA/kainate, TRPV1, ASIC receptors in
spermine-induced nociception
In order to assess the involvement of NMDA, AMPA/kainate or
TRPV1 receptors in the nociceptive responses induced by spermine
(1000 nmol/paw), animals were co-administered with the selective
NMDA receptor antagonist MK 801 (1 nmol/paw), AMPA/kainate
receptor antagonist DNQX (1 nmol/paw), acid-sensitive ion channel
(ASIC) blocker amiloride (100 nmol/paw), TRPV1 receptor antagonist
capsazepine (0.1–1 nmol/paw), the selective TRPV1 receptor antag-
onist SB366791 (1 nmol/paw) or the TRPV1 agonist resiniferatoxin
(RTX; 0.005 pmol/paw). The choice of the dose of antagonists was
based on previous data described in literature (Beirith et al., 2002;
Ferreira et al., 2004; Ferreira et al., 2005; Oliveira et al., 2009; Meiotti
et al., 2010). Control animals received a similar volume of vehicle
(20 μl/paw). To conﬁrm the efﬁcacy of the antagonist tested, we
tested the effect of MK801 (1 nmol/paw) and DNQX (1 nmol/paw) co-administration with glutamate (10,000 nmol/paw), as well as capsa-
zepine (1 nmol/paw) and SB366791 (1 nmol/paw) co-administration
with capsaicin (1 nmol/paw).
2.4. Desensitization of TRPV1 positive ﬁbers in spermine-induced
nociception
To further explore the role of TRPV1 positive (TRPV1+) ﬁbers in
the nociceptive induced by spermine, the animals were submitted to a
systemic desensitization protocol with RTX as previously described by
Hsieh et al. (2008). Animals were anesthetized with isoﬂurane and
received systemic administration of RTX (50 μg/kg) or the vehicle
alone (0.5% ethanol, 0.5% Tween-80, PBS). After 7 days, animals were
submitted to a subcutaneous injection of spermine (1000 nmol/paw,
s.c.), capsaicin (1 nmol/paw, used as a positive control) or vehicle
(0.5% ethanol, 0.5% Tween-80 and PBS) (20 μl/paw).
2.5. TRPV1 receptor expression following systemic RTX treatment
The effect of the systemic treatment with RTX on the expression
of TRPV1 receptors was assessed by Western blot analysis. The
assay was carried out as previously described by Andre et al. (2004)
with minor modiﬁcations. The sciatic nerves were quickly isolated
and were homogenized in a lyses buffer containing 10 mM HEPES,
pH 7.9, 10 M KCl, 2 M MgCl2, 0.1 M ethylenediamine tetraacetic acid
(EDTA), 1 M NaF, 10 μg/ml aprotinin, 10 M β-glycerolphosphate,
1 mM phenylmethanesulphonyl ﬂuoride, 1 M DL-dithiothreitol (DTT)
and 2 M of sodium orthovanadate. After centrifugation (3000×g for
30 min), the supernatant was collected. The protein content was
determined by the method of Bradford (1976), using bovine serum
albumin as a standard. Amounts of 30 μg of protein of sciatic nervewere
mixed in load buffer (200 mM Tris, 10% glycerol, 2% SDS, 2.75 mM β-
mercaptoethanol and 0.04% bromophenol blue) and boiled for 10 min.
Proteins were separated in 10% sodium dodecyl sulfate-polyacrylamide
gels (SDS-PAGE) and transferred to polyvinylidene diﬂuoride mem-
branes, according to the manufacturer's instructions (Perkin Elmer,
USA). The Ponceau staining served as a loading control. After staining
the membranes were dried, scanned and quantiﬁed. Membranes were
processed using a SNAP i.d. system (Millipore, USA), blocked with 1%
BSA in TBS-T (0.05% Tween 20 in Tris–borate saline) and then incubated
for 10 min, with speciﬁc rabbit polyclonal IgG antibodie to anti-TRPV1
(catalog number sc-28759; Santa Cruz Biotechnology, Santa Cruz, CA,
USA) diluted 1:150 in TBS-T. Blots were washed three times with TBS-T
followed by incubation with alkaline phosphatase-coupled secondary
antibody (1:3000) for 10 min. The protein bands were visualized with
5-bromo-4-chloro-3-indolyl phosphate/p-nitro blue tetrazolium sys-
tem (BCIP/NBT). Membranes were dried, scanned and quantiﬁed with
Scion Image PC version of Macintosh compatible NIH image. The TRPV1
western blot had a faint background that was corrected in the image
analysis.
2.6. [3H]-RTX binding assay
Binding assays were carried out as previously described by Andre
et al. (2004) with minor modiﬁcations. To obtain membranes for the
binding studies, the spinal cords (a rich source of vanilloid receptors)
containing the portion between cervical C1 and lumbar L6 segments
of mice were removed and disrupted with the aid of a tissue
homogenizer in ice-cold buffer A, pH 7.4, which contained 5 mM
KCl, 5.8 mM NaCl, 2 mM MgCl2, 0.75 mM CaCl2, 12 mM glucose,
137 mM sucrose, and 10 mM HEPES. The homogenate was ﬁrstly
centrifuged for 10 min at 1000×g in 4 °C. The low-speed pellets were
discarded, and the supernatants were further centrifuged for 30 min
at 35,000×g in 4 °C. The resulting high-speed pellets, re-suspended in
buffer A, were stored at −70 °C until assayed. Binding assays were
carried out in duplicate with a ﬁnal volume of 500 μl, containing buffer
Fig. 1. Dose–response curves for the overt nociception caused by s.c. injection of
capsaicin (0.01–3 nmol/paw), spermine (100–2000 nmol/paw), spermidine (100–
2000 nmol/paw) or putrescine (1000–10,000 nmol/paw) in mice. The effects of the
treatments are expressed as licking time (s). Each bar on the curve represents the mean
of 6–10 animals and vertical lines show the s.e.m.
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(100 μg/protein) and 50 pM [3H]-RTX in absence or presence of
spermine (3–300 μM). For the measurement of non-speciﬁc binding,
100 nm non-radioactive RTX was included in some tubes. Assay
mixtures were set up on ice, and the binding reaction was then
initiated by transferring the assay tubes to a 37 °C water bath. After a
60-minute incubation period, cooling the mixtures on ice terminated
the binding reaction, and then 50 μl of bovine α1-acid glycoprotein
(2 mg/ml) was added to each tube (to allow the detection of speciﬁc
binding). Finally, the bound and free membranes of [3H]-RTX were
separated by centrifuging for 15 min at 20,000×g in 4 °C. The pellet
was quantiﬁed using scintillation counting. Speciﬁc binding was
calculated as the difference between the total and non-speciﬁc
binding.
2.7. Drugs
The following drugs were used: spermine, spermidine, putrescine,
MK801 (5S,10R-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohep-
ten-5,10-imine maleate), DNQX (6,7-dinitroquinoxaline-2,3-dione),
glutamate, resiniferatoxin, capsazepine and capsaicin, SB366791 (N-
(3-methoxyphenyl)-4-chlorocinnamide) (all from Sigma Chemical
Company, St Louis, MO, U.S.A.). The stock solutions of the drugs were
prepared in 1 mM phosphate-buffered solution (PBS) from Sigma
(USA) pH 7.4 in siliconized plastic tubes, maintained at −20 °C and
diluted to the desired concentration just before use. Capsaicin,
capsazepine, SB366791 and resinferatoxin stock solutions were
prepared in absolute ethanol (90%) plus Tween 80 (10%). For drug
administration, the ﬁnal concentration of ethanol and Tween 80 did
not exceed 0.5% and did not cause any detectable effect per se (results
not shown). In addition, radio-labeled [3H]-resiniferatoxin was
purchased from Perkin Elmer (USA).
2.8. Statistical analysis
Results are presented as mean±s.e.m., except ED50 or ID50 values
(i.e., the dose of agonist necessary to produce 50% of the nociceptive
response relative to the maximum effect, or the dose of antagonists
necessary to reduce the agonist response by 50% relative to the control
value, respectively), which are reported as geometric means accom-
panied by their respective 95% conﬁdence limits. ED50 and ID50 values
were calculated, using non-linear regression (sigmoidal dose–
response curve, variable slope) with the GraphPad Prism software.
Emax (maximal effect) and Imax (maximal inhibition) were calculated
based on responses of the control group. The statistical signiﬁcance
between the groups was assessed by means of unpaired Student's t-
test or one-way ANOVA followed by Dunnett's or Student-Newmann–
Keuls' (SNK) test. P-values lower than 0.05 were considered as
indicative of signiﬁcance.
3. Results
3.1. Nociception elicited by peripheral polyamines in mice
The subcutaneously administration of capsaicin (0.01–3 nmol/
paw), spermine spermidine or putrescine (100–10,000 nmol/paw) in
mice produced short-lasting and spontaneous nociception (Fig. 1).
This response started just after the administration and did not last
more than 5 min. The calculated mean ED50 values (and the 95%
conﬁdence limits) for capsaicin, spermine, spermidine or putrescine-
induced licking were 0.16 (0.07–0.39)nmol/paw, 0.4 (0.2–0.7)μmol/
paw, 0.3 (0.1–0.9)μmol/paw and 3.2 (0.9–11.5)μmol/paw, respec-
tively. The maximal nociceptive response caused by capsaicin,
spermine, spermidine and putrescine was 51±4, 70±10, 47±14
and 37±11 s, respectively. Since spermine and spermidine were
more potent than putrescine in producing nociception, we havechosen a sub-maximal dose of spermine (1000 nmol/paw) to study
some mechanisms involved in polyamine-induced nociception.
3.2. Lack of participation of NMDA, AMPA/kainate and ASIC receptors in
the spermine-induced nociception
The selective NMDA receptor antagonist MK-801 (1 nmol/paw)
was not capable of altering spermine-induced nociception
(1000 nmol/paw, Fig. 2A). On the other hand, the co-administration
of MK-801 (1 nmol/paw) partially, but signiﬁcantly, reduced the
nociception caused by glutamate (10,000 nmol/paw, Fig. 2B) with
inhibition of 47±12% compared with the control group. The co-
administration of the selective antagonist AMPA/kainate receptor
DNQX was also not capable of altering spermine-induced nociception
(1000 nmol/paw, Fig. 2C), but partially reduced the nociception
caused by glutamate (10,000 nmol/paw, Fig. 2D), with inhibition of
55±6% compared with the control group. Furthermore, we veriﬁed
that the co-administration of amiloride (100 nmol/paw), an ASIC
receptor blocker, was also not able to modify the nociception induced
by spermine (1000 nmol/paw; Fig. 3). These results suggest that
ionotropic glutamate and ASIC receptors activation did not mediate
spermine-induced nociceptive effect.
3.3. Involvement of TRPV1 receptor in the spermine-induced nociception
We have further assessed the possible role of TRPV1 in spermine-
induced nociception. The co-administration of the TRPV1 antagonist
capsazepine (0.1–1 nmol/paw; s.c.) produced a dose-related and
almost complete inhibition of spermine-induced nociception
(1000 nmol/paw, Fig. 4A). The calculated mean ID50 value for this
effect (and its respective 95% conﬁdence limit) was 0.24 (0.03–1.76)
nmol/paw and the maximal inhibition was 81±10% compared with
the control group. As previously described in literature (Ferreira et al.,
2004; Santos and Calixto, 1997) the co-administration of capsazepine
(1 nmol/paw; s.c.) also largely reduced the capsaicin-induced noci-
ception (1 nmol/paw, Fig. 4B), with inhibition of 80±6% compared
with the control group. To conﬁrm the hypothesis that the spermine-
induced nociception is mediated by TRPV1 receptor, themice received
a co-administration of selective TRPV1 receptor antagonist SB366791
(0.3–10 nmol/paw)with spermine. SB366791 also reduced spermine-
induced nociception (Fig. 4C), with inhibition of 68±9% compared
with the control group and the ID50 was 0.6 (0.3–1.4)nmol/paw.
Fig. 2. Effect of s.c. co-treatment with the selective NMDA receptor antagonist MK 801 (1 nmol/paw) or AMPA/kainate receptor antagonist DNQX (1 nmol/paw) on spermine
(1000 nmol/paw, A and C) or glutamate-induced nociception (10,000 nmol/paw, B and D). Each column represents the mean±s.e.m. of 5–6 mice. Asterisks denote the signiﬁcance
levels. *Pb0.05, ***Pb0.001 compared with glutamate-treated mice (Student's t test).
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the capsaicin-nociception (Fig. 4D), with an inhibition of 72±8%
compared with the control group. These data suggest that the
activation of TRPV1 receptor is an important mechanism underlying
the nociception induced by peripheral injection of spermine in mice.
3.4. Participation of TRPV1 positive ﬁbers in the spermine-induced
nociception
To investigate the role of TRPV1 expressing afferent ﬁbers on
spermine-induced nociception, animals were submitted to a systemic
RTX desensitization protocol. The systemic treatment with RTX
signiﬁcantly reduced the expression of TRPV1 protein in the sciaticFig. 3. Effect of co-treatment with the acid-sensitive ion channel (ASIC) blocker
amiloride (100 nmol/paw) on spermine (1000 nmol/paw, s.c.)-induced nociception in
mice. Each column represents the mean±s.e.m of 6 mice (Student's t test).nerve 7 days after injection, with an inhibition of 67±11% compared
to the control group, conﬁrming a reduction in TRPV1 positive sensory
ﬁbers (Fig. 5A). We observed that pre-treatment with RTX (50 μg/kg,
s.c., 7 days before) largely reduced the capsaicin (1 nmol/paw) or
spermine (1000 nmol/paw)-induced nociception (Fig. 5B), with
inhibitions of 92±4 and 82±9% compared with the control group,
respectively.
3.5. Effect of spermine in resiniferatoxin binding and nociception
To clearly verify the interaction between polyamines with TRPV1
receptor, we performed a speciﬁc binding assay of RTX in presence or
absence of spermine. It was possible to observe that spermine
increases the [3H]-RTX speciﬁc binding in the TRPV1 containing
membranes, with an IC50 value of 54.0 (43.1–67.7) μM and the
maximal effect of 76±5% of speciﬁc binding enhancement when
compared to the control group (Fig. 6A). Again, suggesting that
polyamine-induced nociception is mediated by an interaction with
TRPV1 receptor, we veriﬁed that the co-administration of spermine
with RTX, in doses where they alone produced no nociceptive effect,
resulted in a signiﬁcant nociception (Fig. 6B). These results strongly
reinforce the idea that polyamines induce nociception by facilitating
the activation of TRPV1 receptor.
4. Discussion
Natural polyamines (putrescine, spermidine and spermine) are
aliphatic amines containing two (putrescine), three (spermidine) or
four (spermine) amine groups (Gerner andMeyskens, 2004). It is well
known that they have an important function in the control of the
neuronal excitability through direct interaction with different ion
Fig. 4. Effect of s.c. co-treatment with the TRPV1 receptor antagonists capsazepine (0.1–1 nmol/paw) or SB366791 (0.3–10 nmol/paw) on spermine (1000 nmol/paw, A and C) or
capsaicin-induced nociception (1 nmol/paw, B and D). Each column represents the mean±s.e.m. of 4–8 mice. Asterisks denote the signiﬁcance levels. *Pb0.05, **Pb0.01 compared
with spermine or capsaicin-treated mice (A and C, one-way ANOVA followed by Dunnett's test; B and D, Student's t test).
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ASIC and TRPV1 (Ahern et al., 2006; Babini et al., 2002; Williams,
1997). All these ionic channels are important to the development and
processing of nociception. Since the levels of polyamines are increased
in inﬂammatory processes (Yukioka et al., 1992) and some drugs
acting on polyamines are in clinical trials to treat hyperproliferative
disorders (Gerner andMeyskens, 2004; Rivat et al., 2007), the present
study could indicate new targets to treat painful conditions. In our
study, we have shown that polyamines induced nociception when
injected into the mouse paw by stimulation of the TRPV1 receptor
present in small diameter afferent ﬁbers (Caterina and Julius, 2001).
However, the stimulation of NMDA, AMPA/kainite or ASIC receptors
seems to be not important to spermine-induced spontaneous
nociception.
We have found that exogenous spermine and spermidine, which
are the most charged polyamines, were more potent than putrescine
in producing nociception. Our results are in accordance with some
data demonstrating that some actions of polyamines in ion channels
are charge-dependent (Ahern et al., 2006; Williams, 1997). The pro-
nociceptive action of polyamines found here are also in line with
previous ﬁndings that show that the feeding of rats with a polyamine-
deﬁcient diet may produce analgesic action (Estebe et al., 2006;
Kergozien et al., 1996; Rivat et al., 2007). Thus, both the restriction of
polyamine ingestion and the inhibition of polyamine synthesis could
be interesting targets to control painful processes.
It is well known that the modulation of ion channels, including
ionotropic glutamate receptors, by polyamines (Williams, 1997). In
fact, spermine acts at extracellular sites and at pore in neurons to
potentiate the activity of NMDA, AMPA and kainate receptors,
respectively. It has been hypothesized that these effects of spermine
involve at least two discrete polyamine-binding sites on NMDAreceptors (Williams, 1997). In accordance with these data, it has been
demonstrated that intrathecal (spinal cord) administration of sper-
mine causes hyperalgesia in rats and pain-related behaviors in mice
bymodulation of the NMDA receptor (Tan-No et al., 2000; Kolhekar et
al., 1994). These results indicate that polyamines in spinal cord can
induce nociception through NMDA receptor-stimulation. Further-
more, peripheral administration of NMDA, AMPA/kainite results in
painful behavior in rats (Zhou et al., 1996). In contrast with these data,
our results demonstrated that the peripheral injection of NMDA
receptor antagonist MK 801, in a dose where it is capable of reducing
glutamate-induced nociception, failed in altering intraplantar sper-
mine-induced nociception. Thus, we suggest that the peripheral
mechanisms involved in spermine-induced nociception are different
from the spinal mechanisms. However, the reduction of polyamine-
induced nociception by the NMDA antagonists in spinal cord could be
indirect since the activation of TRPV1 in spinal cord may release
glutamate in vitro (Ueda et al., 1993) and produce an NMDA-mediated
nociception in vivo (Okano et al., 1994). However, further studies
must be carried out to elucidate the role of spinal TRPV1 in the
nociceptive action of intrathecally-injected polyamines.
Another ion channel that has been implicated in some polyamine
action is the acid sensitive ion channel ASIC-1 (Babini et al., 2002). We
found that the non-selective ASIC receptor blocker amiloride was not
able to reduce the spermine-produced nociception in mice in a dose
where it reduced acid-induced nociception (Meotti et al., 2010). Of note,
an in vitro study has showed that polyvalent cations increased the
inactivation of ASIC channel, which could prevent the neuronal
depolarization (Babini et al., 2002). Thus, the action of polyamines on
ASIC-1 should produce antinociceptive effect instead of a pro-
nociceptive action. Moreover, the central nervous system seems to be
the major place to the role of ASIC-1 on nociception regulation
Fig. 5. Western blot analysis showing TRPV1 expression in sciatic nerve (A) after
systemic treatment with RTX (50 mg/kg, s.c.) or with vehicle. Effect of RTX
desensitization (50 mg/kg, s.c.) on spermine (3 μg/paw, s.c.)-induced nociception in
mice (B). Western blot results were represented as arbitrary density unit. Each column
represents the mean±s.e.m of 4–8 mice. Asterisks denote the signiﬁcance levels.
*Pb0.05, ***Pb0.001 in comparison to control group (A, Student's t-test and B, one-way
ANOVA followed by Student-Newman–Keuls' test).
Fig. 6. As speciﬁc binding of [3H] resinferatoxin in spinal cord membranes of mice in
absence or presence of spermine (3–300 μM) in vitro (A). Each point represents the
mean±s.e.m of 3 independent experiments performed in duplicate. Nociceptive effect
caused by the s.c. co-injection of low doses of spermine (100 nmol/paw) with
resinferatoxin (0.005 nmol/paw) (B). Each column represents the mean±s.e.m of 4–
8mice. Asterisks denote the signiﬁcance levels. **Pb0.01 compared to control group (B,
one-way ANOVA followed by Student-Newman–Keuls' test).
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ASIC-1 receptor seems not to be a target related to polyamine-induced
nociception.
Besides ionotropic glutamate and ASIC receptors, polyamines are
also capable of directly stimulating TRPV1, as produce ion selective
changes in this receptor and resulting in Ca2+ inﬂux in sensory neurons
(Ahern et al., 2006; Chung et al., 2008). Furthermore, extracellular
spermine, spermidine and putrescine directly activate and sensitize
TRPV1 in a charge-dependent manner, both in heterologous expression
systems and in sensory neurons (Ahern et al., 2006). Here, we have
shown that both capsazepine and SB366791 largely reduced spermine-
induced nociception with different potencies. Previous studies indeed
show that SB366791 is more potent than capsazepine to antagonize
TRPV1 receptors from rats and humans (Gunthorpe et al., 2004). This
discrepancy may be explained by the fact that the potency and efﬁcacy
of TRPV1 antagonists presents species-speciﬁc differences (McIntyre et
al., 2001). In example, capsazepine fully blocked human and guinea pig
TRPV1 receptor to lowpHand heat, but onlyweakly inhibited rat TRPV1
(McIntyre et al., 2001; Savidge et al., 2002). Unfortunately, there are
previous studies comparing the effects of SB-366791 and capsazepine
on mice TRPV1 receptor. Our data suggest that capsazepine is more
potent than SB366791 to antagonize polyamine-induced nociception in
mice demonstrating a critical role of TRPV1 in the pain-related behavior
caused by peripheral polyamines. However, in vitro studies with mice
TRPV1 receptor must be carried out to conﬁrm this ﬁnding with other
TRPV1 agonists.
Furthermore, it has been well established that the treatment of
animals with agonists of TRPV1 receptor, such as RTX or capsaicin, isable to produce a selective degeneration of TRPV1 positive ﬁbers,
namely sub-types of primary afferent ﬁbers, almost exclusively in
peptidergic C ﬁbers, but also in a small number of Aδ ﬁbers (Ferreira et
al., 2004; Hsieh et al., 2008; Kobayashi et al., 2005). Our data clearly
show that the systemic treatment with RTX signiﬁcantly reduced the
spermine-mediated nociception. This result provides evidence that
spermine and RTX activate the same subpopulation of sensory ﬁbers
that express TRPV1 receptor and consequently produce nociceptive
behavior. The reduction of the TRPV1 protein expression in sciatic
nerve conﬁrmed the efﬁciency of the RTX pre-treatment, which seems
to reach to lumbar dorsal root ganglia (Rashid et al., 2003) and
consequently to reduce TRPV1 protein in sensory neuron terminals.
Experiments with TRPV1 mutants identiﬁed extracellular acidic
residues critical for polyamine regulation since the neutralization of
aspartate 646 (D646N) abolished direct activation by spermine,
whereas neutralization of this same aspartate (D646N) or glutamate
648 (E648A) inhibited spermine-induced sensitization (Ahern et al.,
2006). According to this ﬁnding, we revealed herein that spermine
increased the [3H]-RTX speciﬁc binding in the TRPV1 receptor
containing membranes. We suggest that the RTX and polyamine
binding sites are different, once an increase instead of a competition
for the speciﬁc binding was observed. In accordance to literature
evidence, two residues located in the S2–S3 intracellular loop (Tyr-
511, Ser-512) were found to be critical for RTX binding to TRPV1
channels (Jordt and Julius, 2002). Our ﬁndings suggest that the
polyamine binding on the site in TRPV1 receptor allosterically
increases the afﬁnity of the vanilloid site by its ligands. In fact, the
combination of RTX with spermine, in doses where they did not
produce nociception, resulted in a signiﬁcant nociceptive response.
781C. Gewehr et al. / Pharmacology, Biochemistry and Behavior 99 (2011) 775–781Thus, polyamines found in inﬂamed tissue could increase the binding
of endovanilloids in TRPV1 receptor and contribute to pain production.
Of note, increased levels of polyamines are found in tissue and
synovial ﬂuid from patients with osteoarthritis or rheumatoid,
posttraumatic arthritis and infectious arthritis (Yukioka et al., 1992).
In accordance, spermine concentrations up to millimolar levels have
been reported in inﬂammatory conditions (Zhang et al., 2000).
Interestingly, the doses of polyamines used in our study to cause
spontaneous nociception may be found in inﬂamed tissues, the
concentration of the solution of spermine injected (0.5–150 mM to
generate the doses of 0.01–3 μmol/paw) into the mouse paw is in the
same range of the spermine concentration in synovial tissue of arthritic
patients (about 0.3 mM) (Yukioka et al., 1992). These ﬁndings suggest
again that polyamine action on TRPV1 could contribute to pain
production, especially in inﬂammatory conditions.
Taken together, these data show that polyamines, probably by
virtue of their cationic charge, may increase the activity of TRPV1 in
peripheral terminals of sensory neurons and induce nociception.
Therefore, polyamine regulation of TRPV1 in peripheral tissues may
be relevant to a variety of pathological painful states and represent a
target for the treatment of such conditions.
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